ArticleMolecular cancer therapeutics2017

Role of STAT3 and FOXO1 in the Divergent Therapeutic Responses of Non-metastatic and Metastatic Bladder Cancer Cells to miR-145.

Guosong Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.